Electrically conductive chitosan/carbon scaffolds for cardiac tissue engineering

Biomacromolecules

Volumn 15, Issue 2, 2014, Pages 635-643

  Martins, Ana M ^a,b   Eng, George ^a   Caridade, Sofia G ^b   Mano, Joaão F ^b   Reis, Rui L ^b   Vunjak Novakovic, Gordana ^a  

^a Columbia University ^*  (United States)

^b UNIVERSITY OF MINHO   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIAC TISSUE ENGINEERING; COMPOSITE SCAFFOLDS; ELECTRICAL COUPLING; ELECTRICAL STIMULATIONS; ELECTRICALLY CONDUCTIVE; ENHANCED TRANSMISSION; INTERCONNECTED PORES; MUSCLE CONTRACTIONS;

CARBON NANOFIBERS; CELLS; CHITOSAN; CYTOLOGY; ELECTRIC PROPERTIES; GENE EXPRESSION;

SCAFFOLDS (BIOLOGY);

ATRIAL NATRIURETIC FACTOR; CARBON; CHITOSAN; CONNEXIN 43; GAP JUNCTION PROTEIN; MYOSIN HEAVY CHAIN ALPHA; MYOSIN HEAVY CHAIN BETA; NANOFIBER; TISSUE SCAFFOLD; TRANSCRIPTION FACTOR GATA 4; TROPONIN C; TROPONIN T;

ARTICLE; CONDUCTANCE; CONTROLLED STUDY; ELECTRIC CONDUCTIVITY; ELECTROSTIMULATION; GENE EXPRESSION; HEART; HEART MUSCLE; HEART MUSCLE CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; MUSCLE CONTRACTION; PRECIPITATION; PRIORITY JOURNAL; SCANNING ELECTRON MICROSCOPY; TISSUE ENGINEERING; YOUNG MODULUS; ANIMAL; CELL CULTURE; CHEMISTRY; CYTOLOGY; METABOLISM; RAT; SPRAGUE DAWLEY RAT; TISSUE SCAFFOLD;

ANIMALS; CARBON; CELLS, CULTURED; CHITOSAN; ELECTRIC CONDUCTIVITY; MYOCYTES, CARDIAC; RATS; RATS, SPRAGUE-DAWLEY; TISSUE ENGINEERING; TISSUE SCAFFOLDS;

EID: 84896743805     PISSN: 15257797     EISSN: 15264602     Source Type: Journal    
DOI: 10.1021/bm401679q     Document Type: Article

References (63)

1. Shin, M.; Ishii, O.; Sueda, T.; Vacanti, J. P. Contractile cardiac grafts using a novel nanofibrous mesh. Biomaterials 2004, 25, 3717-3723.
2. Leor, J.; Landa, N.; Cohen, S. Renovation of the injured heart with myocardial tissue engineering. Expert Rev. Cardiovasc. Ther. 2006, 4, 239-252.
3. Yang, M. C.; Wang, S. S.; Chou, N. K.; Chi, N. H.; Huang, Y. Y.; Chang, Y. L.; Shieh, M. J.; Chung, T. W. The cardiomyogenic differentiation of rat mesenchymal stem cells on silk fibroinpolysaccharide cardiac patches in vitro. Biomaterials 2009, 30, 3757-3765.
4. Barsotti, M. C.; Felice, F.; Balbarini, A.; Di Stefano, R. Fibrin as a scaffold for cardiac tissue engineering. Biotechnol. Appl. Biochem. 2011, 58, 301-310.
5. Zhang, T.; Wan, L. Q.; Xiong, Z.; Marsano, A.; Maidhof, R.; Park, M.; Yan, Y. N. A.; Vunjak-Novakovic, G. Channelled scaffolds for engineering myocardium with mechanical stimulation. J. Tissue Eng. Regener. Med. 2012, 6, 748-756.
6. Patra, C.; Talukdar, S.; Novoyatleva, T.; Velagala, S. R.; Muhlfeld, C.; Kundu, B.; Kundu, S. C.; Engel, F. B. Silk protein fibroin from Antheraea mylitta for cardiac tissue engineering. Biomaterials 2012, 33, 2673-2680.
7. Tian, B. Z.; Liu, J.; Dvir, T.; Jin, L. H.; Tsui, J. H.; Qing, Q.; Suo, Z. G.; Langer, R.; Kohane, D. S.; Lieber, C. M. Macroporous nanowire nanoelectronic scaffolds for synthetic tissues. Nat. Mater. 2012, 11, 986-994.
8. Zorlutuna, P.; Elsheikh, A.; Hasirci, V. Nanopatterning of collagen scaffolds improve the mechanical properties of tissue engineered vascular grafts. Biomacromolecules 2009, 10, 814-821.
9. Radisic, M.; Park, H.; Shing, H.; Consi, T.; Schoen, F. J.; Langer, R.; Freed, L. E.; Vunjak-Novakovic, G. Functional assembly of engineered myocardium by electrical stimulation of cardiac myocytes cultured on scaffolds. Proc. Natl. Acad. Sci. U. S. A. 2004, 101, 18129-18134.
10. Tandon, N.; Marsano, A.; Maidhof, R.; Wan, L.; Park, H.; Vunjak-Novakovic, G. Optimization of electrical stimulation parameters for cardiac tissue engineering. J. Tissue Eng. Regener. Med. 2011, 5, E115-E125.
11. Dvir, T.; Timko, B. P.; Brigham, M. D.; Naik, S. R.; Karajanagi, S. S.; Levy, O.; Jin, H. W.; Parker, K. K.; Langer, R.; Kohane, D. S. Nanowired three-dimensional cardiac patches. Nat. Nanotechnol. 2011, 6, 720-725.
12. Maidhof, R.; Tandon, N.; Lee, E. J.; Luo, J. W.; Duan, Y.; Yeager, K.; Konofagou, E.; Vunjak-Novakovic, G. Biomimetic perfusion and electrical stimulation applied in concert improved the assembly of engineered cardiac tissue. J. Tissue Eng. Regener. Med. 2012, 6, e12-e23.
13. Fernandes, E. G. R.; Zucolotto, V.; De Queiroz, A. A. A. Electrospinning of hyperbranched poly-L-lysine/polyaniline nanofibers for application in cardiac tissue engineering. J. Macromol. Sci., Part A 2010, 47, 1203-1207.
14. Stout, D. A.; Basu, B.; Webster, T. J. Poly (lactic-co-glycolic acid): Carbon nanofiber composites for myocardial tissue engineering applications. Acta Biomater. 2011, 7, 3101-3112.
15. You, J. O.; Rafat, M.; Ye, G. J. C.; Auguste, D. T. Nanoengineering the heart: conductive scaffolds enhance Connexin 43 expression. Nano Lett. 2011, 11, 3643-3648.
16. Borriello, A.; Guarino, V.; Schiavo, L.; Alvarez-Perez, M. A.; Ambrosio, L. Optimizing PANi doped electroactive substrates as patches for the regeneration of cardiac muscle. J. Mater. Sci.: Mater. Med. 2011, 22, 1053-1062.
17. Stout, D. A.; Yoo, J.; Santiago-Miranda, A. N.; Webster, T. J. Mechanisms of greater cardiomyocyte functions on conductive nanoengineered composites for cardiovascular applications. Int. J. Nanomed. 2012, 7, 5653-5669.
18. Martins, A. M.; Santos, M. I.; Azevedo, H. S.; Malafaya, P. B.; Reis, R. L. Natural origin scaffolds with in situ pore forming capability for bone tissue engineering applications. Acta Biomater. 2008, 4, 1637-1645.
19. Martins, A. M.; Pham, Q. P.; Malafaya, P. B.; Raphael, R. M.; Kasper, F. K.; Reis, R. L.; Mikos, A. G. "Smart" and stimulus responsive chitosan-based scaffolds/cells for bone tissue engineering: Influence of lysozyme upon scaffold degradation and osteogenic differentiation of cultured marrow stromal cells induced by cap coatings. Tissue Eng., Part A 2008, 14, 795-795.
20. Martins, A. M.; Alves, C. M.; Kasper, F. K.; Mikos, A. G.; Reis, R. L. Responsive and in situ-forming chitosan scaffolds for bone tissue engineering applications: an overview of the last decade. J. Mater. Chem. 2010, 20, 1638-1645.
21. Martins, A. M.; Kretlow, J. D.; Costa-Pinto, A. R.; Malafaya, P. B.; Fernandes, E. M.; Neves, N. M.; Alves, C. M.; Mikos, A. G.; Kasper, F. K.; Reis, R. L. Gradual pore formation in natural origin scaffolds throughout subcutaneous implantation. J. Biomed. Mater. Res., A 2012, 100, 599-612.
22. Madihally, S. V.; Matthew, H. W. Porous chitosan scaffolds for tissue engineering. Biomaterials 1999, 20, 1133-1142.
23. Ueno, H.; Mori, T.; Fujinaga, T. Topical formulations and wound healing applications of chitosan. Adv. Drug Delivery Rev. 2001, 52, 105-115.
24. Hoekstra, A.; Struszczyk, H.; Kivekas, O. Percutaneous microcrystalline chitosan application for sealing arterial puncture sites. Biomaterials 1998, 19, 1467-1471.
25. Kumar, M. N. V. R. A review of chitin and chitosan applications. React. Funct. Polym. 2000, 46, 1-27.
26. Khor, E. Chitin: a biomaterial in waiting. Curr. Opin. Solid State Mater. Sci. 2002, 6, 313-317.
27. Lu, W. N.; Lu, S. H.; Wang, H. B.; Li, D. X.; Duan, C. M.; Liu, Z. Q.; Hao, T.; He, W. J.; Xu, B.; Fu, Q.; Song, Y. C.; Xie, X. H.; Wang, C. Y. Functional improvement of infarcted heart by co-injection of embryonic stem cells with temperature-responsive chitosan hydrogel. Tissue Eng., Part A 2009, 15, 1437-1447.
28. Wang, H. B.; Zhang, X. L.; Li, Y. M.; Ma, Y. T.; Zhang, Y.; Liu, Z. G.; Zhou, J.; Lin, Q. X.; Wang, Y. M.; Duan, C. M.; Wang, C. Y. Improved myocardial performance in infarcted rat heart by coinjection of basic fibroblast growth factor with temperature-responsive Chitosan hydrogel. J. Heart Lung Transpl. 2010, 29, 881-887.
29. Liu, Z. Q.; Wang, H. B.; Wang, Y.; Lin, Q. X.; Yao, A. N.; Cao, F.; Li, D. X.; Zhou, J.; Duan, C. M.; Du, Z. Y.; Wang, Y. M.; Wang, C. Y. The influence of chitosan hydrogel on stem cell engraftment, survival and homing in the ischemic myocardial microenvironment. Biomaterials 2012, 33, 3093-3106.
30. Vamvakaki, V.; Tsagaraki, K.; Chaniotakis, N. Carbon nanofiberbased glucose biosensor. Anal. Chem. 2006, 78, 5538-5542.
31. Wu, L.; Lei, J. P.; Zhang, X. J.; Ju, H. X. Biofunctional nanocomposite of carbon nanofiber with water-soluble porphyrin for highly sensitive ethanol biosensing. Biosens. Bioelectron. 2008, 24, 644-649.
32. Tran, P. A.; Zhang, L. J.; Webster, T. J. Carbon nanofibers and carbon nanotubes in regenerative medicine. Adv. Drug Delivery Rev. 2009, 61, 1097-1114.
33. Wang, S. F.; Shen, L.; Zhang, W. D.; Tong, Y. J. Preparation and mechanical properties of chitosan/carbon nanotubes composites. Biomacromolecules 2005, 6, 3067-3072.
34. Lau, C.; Cooney, M. J.; Atanassov, P. Conductive macroporous composite chitosan-carbon nanotube scaffolds. Langmuir 2008, 24, 7004-7010.
35. Livak, K. J.; Schmittgen, T. D. Analysis of relative gene expression data using real-time quantitative PCR and the 2 (T) (-δδC) method. Methods 2001, 25, 402-408.
36. Mano, J. C.; Reis, R. L.; Cunha, A. M. Dynamic Mechanical Analysis in Polymers for Biomedical Applications. In Polymer Based Systems on Tissue Engineering, Replacement and Regeneration; Reis, R. L., Cohn, D, Eds.; Dordrecht: Kluwer, 2002; p 139-164.
37. Engler, A. J.; Sen, S.; Sweeney, H. L.; Discher, D. E. Matrix elasticity directs stem cell lineage specification. Cell 2006, 126, 677-689.
38. Berry, M. F.; Engler, A. J.; Woo, Y. J.; Pirolli, T. J.; Bish, L. T.; Jayasankar, V.; Morine, K. J.; Gardner, T. J.; Discher, D. E.; Sweeney, H. L. Mesenchymal stem cell injection after myocardial infarction improves myocardial compliance. Am. J. Physiol. 2006, 290, H2196-H2203.
39. Mavrilas, D.; Sinouris, E. A.; Vynios, D. H.; Papageorgakopoulou, N. Dynamic mechanical characteristics of intact and structurally modified bovine pericardial tissues. J. Biomech. 2005, 38, 761-768.
40. Hankiewi, J.; Swiercze, E. Lysozyme in human body fluids. Clin. Chim. Acta 1974, 57, 205-209.
41. Porstmann, B.; Jung, K.; Schmechta, H.; Evers, U.; Pergande, M.; Porstmann, T.; Kramm, H. J.; Krause, H. Measurement of lysozyme in human body fluids: comparison of various enzymeimmunoassay techniques and their diagnostic application. Clin. Biochem. 1989, 22, 349-355.
42. Varum, K. M.; Myhr, M. M.; Hjerde, R. J. N.; Smidsrod, O. In vitro degradation rates of partially N-acetylated chitosans in human serum. Carbohydr. Res. 1997, 299, 99-101.
43. Tomihata, K.; Ikada, Y. In vitro and in vivo degradation of films of chitin and its deacetylated derivatives. Biomaterials 1997, 18, 567-575.
44. Martins, A. M.; Pereira, R. C.; Leonor, I. B.; Azevedo, H. S.; Reis, R. L. Chitosan scaffolds incorporating lysozyme into CaP coatings produced by a biomimetic route: A novel concept for tissue engineering combining a self-regulated degradation system with in situ pore formation. Acta Biomater. 2009, 5, 3328-3336.
45. Potse, M.; Dube, B.; Vinet, A. Cardiac anisotropy in boundaryelement models for the electrocardiogram. Med. Biol. Eng. Comput. 2009, 47, 719-729.
46. Nag, A. C. Study of non-muscle cells of the adult mammalian heart: a fine-structural analysis and distribution. Cytobios 1980, 28, 41-61.
47. Severs, N. J. The cardiac muscle cell. Bioessays 2000, 22, 188-199.
48. Davis, M. E.; Hsieh, P. C.; Grodzinsky, A. J.; Lee, R. T. Custom design of the cardiac microenvironment with biomaterials. Circ. Res. 2005, 97, 8-15.
49. Ling-Ling, E.; Zhao, Y. S.; Guo, X. M.; Wang, C. Y.; Jiang, H.; Li, J.; Duan, C. M.; Song, Y. Enrichment of cardiomyocytes derived from mouse embryonic stem cells. J. Heart Lung Transpl. 2006, 25, 664-674.
50. Lo, C. W. Role of gap junctions in cardiac conduction and development: insights from the connexin knockout mice. Circ. Res. 2000, 87, 346-348.
51. Vaidya, D.; Tamaddon, H. S.; Lo, C. W.; Taffet, S. M.; Delmar, M.; Morley, G. E.; Jalife, J. Null mutation of connexin43 causes slow propagation of ventricular activation in the late stages of mouse embryonic development. Circ. Res. 2001, 88, 1196-1202.
52. Kostin, S.; Dammer, S.; Hein, S.; Klovekorn, W. P.; Bauer, E. P.; Schaper, J. Connexin 43 expression and distribution in compensated and decompensated cardiac hypertrophy in patients with aortic stenosis. Cardiovasc. Res. 2004, 62, 426-436.
53. Temsah, R.; Nemer, M. GATA factors and transcriptional regulation of cardiac natriuretic peptide genes. Regul. Pept. 2005, 128, 177-185.
54. Hosoda, T.; Monzen, K.; Hiroi, Y.; Oka, T.; Takimoto, E.; Yazaki, Y.; Nagai, R.; Komuro, I. A novel myocyte-specific gene Midori promotes the differentiation of P19CL6 cells into cardiomyocytes. J. Biol. Chem. 2001, 276, 35978-35989.
55. Aries, A.; Paradis, P.; Lefebvre, C.; Schwartz, R. J.; Nemer, M. Essential role of GATA-4 in cell survival and drug-induced cardiotoxicity. Proc. Natl. Acad. Sci. U. S. A. 2004, 101, 6975-6980.
56. Zammit, P. S.; Kelly, R. G.; Franco, D.; Brown, N.; Moorman, A. F.; Buckingham, M. E. Suppression of atrial myosin gene expression occurs independently in the left and right ventricles of the developing mouse heart. Dev. Dynam. 2000, 217, 75-85.
57. Bin, Z.; Sheng, L. G.; Gang, Z. C.; Hong, J.; Jun, C.; Bo, Y.; Hui, S. Efficient cardiomyocyte differentiation of embryonic stem cells by bone morphogenetic protein-2 combined with visceral endoderm-like cells. Cell Biol. Int. 2006, 30, 769-776.
58. Saggin, L.; Ausoni, S.; Gorza, L.; Sartore, S.; Schiaffino, S. Troponin-T switching in the developing rat-heart. J. Biol. Chem. 1988, 263, 18488-18492.
59. Kodama, H.; Inoue, T.; Watanabe, R.; Yasuoka, H.; Kawakami, Y.; Ogawa, S.; Ikeda, Y.; Mikoshiba, K.; Kuwana, M. Cardiomyogenic potential of mesenchymal progenitors derived from human circulating CD14 (+) monocytes. Stem Cells Dev. 2005, 14, 676-686.
60. Oka, T.; Maillet, M.; Watt, A. J.; Schwartz, R. J.; Aronow, B. J.; Duncan, S. A.; Molkentin, J. D. Cardiac-specific deletion of Gata4 reveals its requirement for hypertrophy, compensation, and myocyte viability. Circ. Res. 2006, 98, 837-845.
61. Dang, X. T.; Doble, B. W.; Kardami, E. The carboxy-tail of connexin-43 localizes to the nucleus and inhibits cell growth. Mol. Cell. Biochem. 2003, 242, 35-38.
62. Boengler, K.; Heusch, G.; Schulz, R. Connexin 43 and ischemic preconditioning: effects of age and disease. Exp. Gerontol. 2006, 41, 485-488.
63. Kawase, Y.; Ly, H. Q.; Prunier, F.; Lebeche, D.; Shi, Y. F.; Jin, H. W.; Hadri, L.; Yoneyama, R.; Hoshino, K.; Takewa, Y.; Sakata, S.; Peluso, R.; Zsebo, K.; Gwathmey, J. K.; Tardif, J. C.; Tanguay, J. F.; Hajar, R. J. Reversal of cardiac dysfunction after long-term expression of SERCA2a by gene transfer in a pre-clinical model of heart failure. J. Am. Coll. Cardiol. 2008, 51, 1112-1119.